The notion of LDL receptor-mediated endocytosis as a protective mechanism in metabolic disorders such as NAFLD is underscored by the severely inflamed liver phenotype resembling NASH found in LDLR knock-out models[26]. Here, LDLR is linked to metabolic dysfunction-associated steatotic liver disease.